Hubei Goto Biopharm Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 604.4 million compared to CNY 588.37 million a year ago. Revenue was CNY 604.57 million compared to CNY 590.89 million a year ago.

Net income was CNY 40.19 million compared to CNY 78.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.3486 compared to CNY 0.7417 a year ago. Diluted earnings per share from continuing operations was CNY 0.3486 compared to CNY 0.7417 a year ago.